RELATIONSHIP OF APOLIPOPROTEIN-E PHENOTYPES TO HYPOCHOLESTEROLEMIA

被引:17
|
作者
SNYDER, SM
TERDIMAN, JF
CAAN, B
FEINGOLD, KR
HUBL, ST
SMITH, RS
YOUNG, SG
机构
[1] KAISER PERMANENTE MED CARE PROGRAM,DIV RES,3451 PIEDMONT AVE,OAKLAND,CA 94611
[2] UNIV CALIF BERKELEY,DEPT BIOCHEM,BERKELEY,CA 94720
[3] KAISER PERMANENTE MED CTR,DEPT MED,SAN FRANCISCO,CA
[4] VET ADM MED CTR,DEPT MED,SAN FRANCISCO,CA
[5] JOHNSON & JOHNSON BIOTECHNOL CTR,SAN DIEGO,CA
[6] UNIV CALIF SAN FRANCISCO,DEPT MED,CARDIOVASC RES INST,GLADSTONE FDN LABS,SAN FRANCISCO,CA 94143
来源
AMERICAN JOURNAL OF MEDICINE | 1993年 / 95卷 / 05期
关键词
D O I
10.1016/0002-9343(93)90330-R
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
PURPOSE: Persons with total cholesterol (TC) levels less than 130 mg/dL (less than 3.26 mmol/L) make up less than 1 % of a healthy population. Causes of hypocholesterolemia include a diet very low in cholesterol and saturated fat, disease, gene tic factors (including low apolipoprotein B-100 [apo B-100] and the apo E allele), and drug therapy. The purpose of this study was to determine the causes of hypocholesterolemia in a healthy Kaiser Foundation Health Plan (KFHP) population. PATIENTS AND METHODs: We conducted a dietary and health survey of 201 healthy hypocholesterolemic adults (range: 2.04 to 3.88 mmol/L [79 to 150 mg/dL]) and 200 matched control subjects with TC levels in the middle quintile of the population (range: 5.0 to 5.61 mmol/L [194 to 217 mg/dL]) who had routine health screening from 1983 through 1985. We did apo E phenotyping studies and lipid and apo A-1 and B-100 measurements in a subgroup of 45 hypocholesterolemic subjects (mean TC level: 3.26 mmol/L [126 mg/dL]) and in a comparison group of 49 unmatched volunteers (mean TC level: 5.04 +/- 0.75 mmol/L [ 195 +/- 29 mg/dL]). RESULTS: We found no differences in dietary intake or clinically significant medical illness between hyrocholesterolemic and control subjects. In the hypocholesterolemic subgroup, we found an increased frequency of the apo E2 allele (epsilon2) and a decreased frequency of the apo E4 allele (espilon4); the frequencies of the epsilon2, epsilon3, and epsilon4 alleles were 33.3 %, 63.3%, and 3.3%, respectively. The corresponding apo E allele frequencies in the comparison subgroup were 8.2%, 73.5 %, and 18.4%, similar to those previously reported for the general population and significantly different from those found in the hypocholesterolemic subgroup (p <0.0001). One hypocholesterolemic subject (a 46th patient) had a mutation in the apo B gene that resulted in the synthesis of a truncated species of apo B (apo B-46). CONCLUSION: Our study indicates that hypocholesterolemia in our KFHP urban population is usually not caused by diet or disease. Biochemical factors, including the increased frequency of the apo E-2 phenotype and the decreased frequency of the apo E-4 phenotype, are more important.
引用
收藏
页码:480 / 488
页数:9
相关论文
共 50 条
  • [1] APOLIPOPROTEIN-E PHENOTYPES AND HYPERLIPIDEMIA
    UTERMANN, G
    KINDERMANN, I
    KAFFARNIK, H
    STEINMETZ, A
    HUMAN GENETICS, 1984, 65 (03) : 232 - 236
  • [2] DISTRIBUTION OF APOLIPOPROTEIN-E PHENOTYPES IN FRIEDREICHS ATAXIA
    BOUTHILLIER, D
    NESTRUCK, AC
    MILNE, R
    SING, CF
    BARBEAU, A
    DAVIGNON, J
    CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 1984, 11 (04) : 626 - 630
  • [3] APOLIPOPROTEIN-E PHENOTYPES OF NORMOLIPOPROTEINEMIA AND HYPERLIPOPROTEINEMIA IN JAPANESE
    SANO, R
    ABE, R
    OIKAWA, S
    FUJII, Y
    HORI, S
    SUZUKI, N
    TOYOTA, T
    GOTO, Y
    TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE, 1988, 154 (03): : 297 - 303
  • [4] APOLIPOPROTEIN-E PHENOTYPES, LIPOPROTEIN COMPOSITION, AND XANTHELASMAS
    GOMEZ, JA
    GONZALEZ, MJ
    DEMORAGAS, JM
    SERRAT, J
    GONZALEZSASTRE, F
    PEREZ, M
    ARCHIVES OF DERMATOLOGY, 1988, 124 (08) : 1230 - 1234
  • [5] APOLIPOPROTEIN-E PHENOTYPES IN PATIENTS WITH MYOCARDIAL-INFARCTION
    UTERMANN, G
    HARDEWIG, A
    ZIMMER, F
    HUMAN GENETICS, 1984, 65 (03) : 237 - 241
  • [6] APOLIPOPROTEIN-E PHENOTYPES IN HYPERLIPEMIC PATIENTS AND THEIR IMPLICATIONS FOR TREATMENT
    JANUS, ED
    GRANT, S
    LINTOTT, CJ
    WARDELL, MR
    ATHEROSCLEROSIS, 1985, 57 (2-3) : 249 - 266
  • [7] APOLIPOPROTEIN-E PHENOTYPES IN PATIENTS WITH GOUT - RELATION WITH HYPERTRIGLYCERIDEMIA
    MORIWAKI, Y
    YAMAMOTO, T
    TAKAHASHI, S
    TSUTSUMI, Z
    HIGASHINO, K
    ANNALS OF THE RHEUMATIC DISEASES, 1995, 54 (05) : 351 - 354
  • [8] PHENOTYPES OF APOLIPOPROTEIN-B AND APOLIPOPROTEIN-E AFTER LIVER-TRANSPLANTATION
    LINTON, MF
    GISH, R
    HUBL, ST
    BUTLER, E
    ESQUIVEL, C
    BRY, WI
    BOYLES, JK
    WARDELL, MR
    YOUNG, SG
    JOURNAL OF CLINICAL INVESTIGATION, 1991, 88 (01): : 270 - 281
  • [9] LIPID-METABOLISM AND APOLIPOPROTEIN-E PHENOTYPES IN PATIENTS WITH XANTHELASMA
    RIBERA, M
    PINTO, X
    ARGIMON, JM
    FIOL, C
    PUJOL, R
    FERRANDIZ, C
    AMERICAN JOURNAL OF MEDICINE, 1995, 99 (05): : 485 - 490
  • [10] APOLIPOPROTEIN-E PHENOTYPES IN PATIENTS WITH CORONARY-ARTERY DISEASE
    MIIDA, T
    TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE, 1990, 160 (03): : 177 - 187